Independent associations of HCV RNA status and covariates with CMV IgG (IU/mL)^a.

aResults from a single multivariable linear regression model of N = 584 women who were both CMV and EBV seropositive and had CD4+ T-cell data at their CMV testing visit. bWomen who were HCVAb+/HCV RNA+ at enrollment were defined to be HCV RNA+ while those who were HCV Ab+/HCV RNA- and HCVAb- at enrollment were defined to be HCV RNA-. Follow-up HCV RNA testing was conducted on all women who were HCVAb+ at enrollment and HCV RNA status was 100% concordant between enrollment and follow-up testing. Follow-up testing of HCVAb- women was not conducted (see Laboratory Methods and Discussion). cAge tertiles. Low: <37.6; Middle: 37.6–45.3; High: >45.3. dUntreated: no receipt of HAART; Treated and aviremic: undetectable HIV RNA for ≥50% of study visits following first reported receipt of HAART; Treated and viremic: HIV RNA levels above the lower level of detection for >50% of study visits following first reported receipt of HAART.